Loading live market data…

ImmunityBio, Inc.

NASDAQ:IBRX

$7.88 USD

$0.09 (1.16%)

Volume
7.47M
Average Volume
13.62M
Market Capitalization
$8.25B
P/E Ratio
-9.23
Dividend Yield
0.00%
Price Target
$12.00
Year High
$12.43
Year Low
$1.95
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$6.67

IBRX Estimated and Actual Revenue by Quarter

IBRX Estimated and Actual EPS by Quarter

IBRX Analyst Forecasts

Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2028-12-31 1 -401.41M -305.62M -352.1M -401.41M -305.62M -352.1M
2028-09-30 1 -385.97M -293.87M -338.55M -385.97M -293.87M -338.55M
2028-06-30 1 -385.97M -293.87M -338.55M -385.97M -293.87M -338.55M
2028-03-31 1 -370.53M -282.11M -325.01M -370.53M -282.11M -325.01M
2027-12-31 1 -96.99M -73.84M -85.07M -96.99M -73.84M -85.07M
2027-09-30 1 -81.23M -61.85M -71.25M -81.23M -61.85M -71.25M
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2028-12-31 1 114.5M 163.39M 138.22M 48.53B 63.74B 55.91B
2028-09-30 1 114.16M 162.89M 137.81M 46.66B 61.28B 53.76B
2028-06-30 1 118.41M 168.97M 142.94M 46.66B 61.28B 53.76B
2028-03-31 1 95.02M 135.59M 114.7M 44.79B 58.83B 51.61B
2027-12-31 1 -97.11M -68.05M -82.15M 11.72B 15.4B 13.51B
2027-09-30 1 -97.11M -68.05M -82.15M 9.82B 12.9B 11.31B
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2028-12-31 1 305.62M 401.41M 352.1M 1 0.1115 0.15911 0.1346
2028-09-30 1 293.87M 385.97M 338.55M 1 0.11117 0.15863 0.1342
2028-06-30 1 293.87M 385.97M 338.55M 1 0.11531 0.16455 0.1392
2028-03-31 1 282.11M 370.53M 325.01M 1 0.09253237 0.13204 0.1117
2027-12-31 1 73.84M 96.99M 85.07M 1 -0.09456629 -0.06627206 -0.08
2027-09-30 1 61.85M 81.23M 71.25M 1 -0.09456629 -0.06627206 -0.08